Interferons in relapsing remitting multiple sclerosis.

Interferons in relapsing remitting multiple sclerosis.

Библиографические подробности
Главный автор:	Goodin, D
Формат:	Journal article
Язык:	English
Опубликовано:	2003

Схожие документы

Interferons in relapsing remitting multiple sclerosis - Authors' reply
по: Filippini, G, и др.
Опубликовано: (2003)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
по: Filippini, G, и др.
Опубликовано: (2003)

Interferons in relapsing remitting multiple sclerosis: a systematic review.
по: Filippini, G, и др.
Опубликовано: (2003)

Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
по: Dian HE, и др.
Опубликовано: (2014-09-01)

Erratum to Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
по: Dian HE
Опубликовано: (2015-01-01)

Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: is there a one odd out?
по: Alexis Clapin
Опубликовано: (2012-09-01)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
по: Làzaro Aurelio Vàzquez Gòmez, и др.
Опубликовано: (2022-10-01)

Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.
по: Wylezinska, M, и др.
Опубликовано: (2003)

Thalamic neurodegeneration in relapsing: Remitting multiple sclerosis
по: Cifelli, A, и др.
Опубликовано: (2003)

Comorbidity in in patients with relapsing-remitting multiple sclerosis
по: O.V. Somilo, и др.
Опубликовано: (2024-10-01)

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
по: Burcu Altunrende, и др.
Опубликовано: (2017-12-01)

Advances in the treatment of relapsing - Remitting multiple sclerosis
по: Radu Tanasescu, и др.
Опубликовано: (2014-04-01)

Postural Control in Relapsing-Remitting Multiple Sclerosis
по: Flavia Salvaterra Cusin, и др.
Опубликовано: (2022-10-01)

Multiple Sclerosis Relapsing Remitting Progressive Type
по: Nora Fitri, и др.
Опубликовано: (2020-12-01)

Direct costs of relapses in patients with relapsing-remitting multiple sclerosis
по: V. Casado, и др.
Опубликовано: (2021-07-01)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis.
по: Petkau, A, и др.
Опубликовано: (2004)

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis
по: Petkau, A, и др.
Опубликовано: (2004)

Cost-utility analysis of interferon beta-1a (Avonex and Cinnovex) for relapsing remitting multiple sclerosis
по: Rahil Sadat Shahtaheri, и др.
Опубликовано: (2018-06-01)

Experience with the long-term use of interferons β in the treatment of relapsing-remitting multiple sclerosis. Case report
по: Taras O. Simaniv, и др.
Опубликовано: (2024-12-01)

Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
по: Fernando Rodríguez-Jorge, и др.
Опубликовано: (2024-11-01)

Oxidative stress in relapsing-remitting multiple sclerosis patients
по: Samaneh Sabouri, и др.
Опубликовано: (2023-09-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
по: V. M. Alifirova, и др.
Опубликовано: (2010-08-01)

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
по: Halil Önder
Опубликовано: (2019-06-01)

Serum prolactin in patients with relapsing remitting multiple sclerosis
по: Hoda A. Alwakil, и др.
Опубликовано: (2020-07-01)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
по: Burgal María, и др.
Опубликовано: (2010-04-01)

Mild cognitive impairment in relapsing-remitting multiple sclerosis
по: Dimakopoulou Aikaterini, и др.
Опубликовано: (2008-04-01)

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
по: Damiano Paolicelli, и др.
Опубликовано: (2016-01-01)

Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing–Remitting-Multiple Sclerosis Patients
по: Chiara D’Angelo, и др.
Опубликовано: (2018-06-01)

Cerebellar information processing in relapsing-remitting multiple sclerosis (RRMS).
по: Lesage, E, и др.
Опубликовано: (2010)

Cerebellar Information Processing in Relapsing-Remitting Multiple Sclerosis (RRMS)
по: E. Lesage, и др.
Опубликовано: (2010-01-01)

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
по: Lugaresi A, и др.
Опубликовано: (2013-06-01)

Management of relapsing-remitting multiple sclerosis: diagnosis and treatment guidelines
по: Paty, D, и др.
Опубликовано: (1999)

Subtypes of relapsing-remitting multiple sclerosis identified by network analysis
по: Quentin Howlett-Prieto, и др.
Опубликовано: (2023-01-01)

Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis
по: Forooz Peiravian, и др.
Опубликовано: (2016-09-01)

Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
по: Fernando Rodríguez-Jorge, и др.
Опубликовано: (2024-12-01)

Prooxidant-antioxidant balance in relapsing-remitting multiple sclerosis patients
по: Samaneh Sabouri, и др.
Опубликовано: (2023-07-01)

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
по: Sainz de la Maza S, и др.
Опубликовано: (2023-06-01)

Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
по: Roberto Bomprezzi
Опубликовано: (2015-01-01)

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
по: Romme Christensen Jeppe, и др.
Опубликовано: (2012-09-01)

Systematic review of prediction models in relapsing remitting multiple sclerosis.
по: Fraser S Brown, и др.
Опубликовано: (2020-01-01)